Skip to main content
SpringerLink
Log in

Antipsychotic compliance valuable in schizophrenia

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Damen J, Heeg BMS, Lothgren M, van Hout BA.A pharmacoeconomic analysis of compliance gains on antipsychotic medications. Value in Health 10: A294 (plus poster) abstr. PMH22, No. 6, Nov-Dec 2007

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Antipsychotic compliance valuable in schizophrenia. Pharmacoecon. Outcomes News 541, 6 (2007). https://doi.org/10.2165/00151234-200705410-00007

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200705410-00007

Keywords

Search

Navigation